93 related articles for article (PubMed ID: 15850524)
1. [Treatment of chronic hepatitis C with peginterferon alpha-2a and the factors influencing the effect of this treatment].
Jin GD; Gong QM; Mao HJ; Xu DZ; Lu ZM
Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):302-4. PubMed ID: 15850524
[No Abstract] [Full Text] [Related]
2. Antiviral effect of peginterferon alfa-2b and alfa-2a compared.
Jansen PL; Reesink HW
J Hepatol; 2006 Aug; 45(2):172-3. PubMed ID: 16797101
[No Abstract] [Full Text] [Related]
3. Proceed with caution: peginterferon alpha-2a versus peginterferon alfa-2b in chronic hepatitis C. A systematic review of randomized trials.
Kershenobich D; Muñoz L; Malé R; Gaytan J; Sánchez F
Hepatology; 2010 Dec; 52(6):2240-1; author reply 2241-2. PubMed ID: 21105116
[No Abstract] [Full Text] [Related]
4. Comment on a systematic review of randomized trials of peginterferon alpha-2a versus peginterferon alpha-2b in chronic hepatitis C.
Singal AK; Jampana SC; Anand BS
Hepatology; 2011 Jun; 53(6):2151. PubMed ID: 21538429
[No Abstract] [Full Text] [Related]
5. [Peginterferon alpha-2a and ribavirin for treating chronic hepatitis C patients with persistent normal aminotransferase levels].
Jiang TJ; Fan R; Xie YX; Zhao P; Zhang X; Zhao M; Zhou ZP; He J
Zhonghua Gan Zang Bing Za Zhi; 2008 Apr; 16(4):307-8. PubMed ID: 18423159
[No Abstract] [Full Text] [Related]
6. Peginterferon alpha-2a improved the hepatitis C virologic response in concurrent HIV and chronic hepatitis C virus infections.
Torriani FJ; Chung RT
ACP J Club; 2005; 142(1):A12; author reply A13. PubMed ID: 15656540
[No Abstract] [Full Text] [Related]
7. Peginterferon alfa-2a in patients with chronic hepatitis C.
Zeuzem S; Feinman SV; Rasenack J; Heathcote EJ; Lai MY; Gane E; O'Grady J; Reichen J; Diago M; Lin A; Hoffman J; Brunda MJ
N Engl J Med; 2000 Dec; 343(23):1666-72. PubMed ID: 11106715
[TBL] [Abstract][Full Text] [Related]
8. Peginterferon and ribavirin for hepatitis C.
Abramowicz M
N Engl J Med; 2007 Mar; 356(12):1270-1; author reply 1271. PubMed ID: 17378100
[No Abstract] [Full Text] [Related]
9. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
[TBL] [Abstract][Full Text] [Related]
10. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C.
Rakov NE
N Engl J Med; 2003 Jan; 348(3):259-60; author reply 259-60. PubMed ID: 12529472
[No Abstract] [Full Text] [Related]
11. [High dose of pegylated interferon alpha-2a for the treatment of genotype1 chronic hepatitis C: a case report].
Wu CH; Wang LF; Xu XY
Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):873. PubMed ID: 21138646
[No Abstract] [Full Text] [Related]
12. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.
Heathcote EJ; Shiffman ML; Cooksley WG; Dusheiko GM; Lee SS; Balart L; Reindollar R; Reddy RK; Wright TL; Lin A; Hoffman J; De Pamphilis J
N Engl J Med; 2000 Dec; 343(23):1673-80. PubMed ID: 11106716
[TBL] [Abstract][Full Text] [Related]
13. Effect of pegylated interferon treatments for chronic active hepatitis C on quality of life.
Nayman Alpat S; Usluer G; Yavuz H; Doyuk Kartal E; Erben N; Bal C; Ozgunes I
J Chemother; 2008 Feb; 20(1):101-5. PubMed ID: 18343751
[TBL] [Abstract][Full Text] [Related]
14. Peginterferon and ribavirin for chronic hepatitis C.
Hoofnagle JH; Seeff LB
N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366
[No Abstract] [Full Text] [Related]
15. Peginterferon and ribavirin for hepatitis C.
Duggan AE; Duggan JM
N Engl J Med; 2007 Mar; 356(12):1269; author reply 1271. PubMed ID: 17377169
[No Abstract] [Full Text] [Related]
16. [A 72 week follow-up study of chronic hepatitis C patients treated with peginterferon alfa-2b and ribavirin].
Yu SL; Zhang ZH; Lv H; Zhang QG; Wang YZ
Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):231. PubMed ID: 17407724
[No Abstract] [Full Text] [Related]
17. Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a.
Sarrazin C; Hendricks DA; Sedarati F; Zeuzem S
J Clin Microbiol; 2001 Aug; 39(8):2850-5. PubMed ID: 11474002
[TBL] [Abstract][Full Text] [Related]
18. Antibodies neutralizing peginterferon alfa during retreatment of hepatitis C.
van der Eijk AA; Vrolijk JM; Haagmans BL
N Engl J Med; 2006 Mar; 354(12):1323-4. PubMed ID: 16554542
[No Abstract] [Full Text] [Related]
19. [Successful therapy with pegylated interferon alfa-2a. Hepatitis C patients remain virus-free].
MMW Fortschr Med; 2003 Sep; 145(35-36):56. PubMed ID: 14584218
[No Abstract] [Full Text] [Related]
20. [Pegasys: FDA approved Pegasys (peginterferon alfa-2a) for the treatment of hepatitis C].
Iafolla M
Sidahora; 2002; (4):8-10. PubMed ID: 12703472
[No Abstract] [Full Text] [Related]
[Next] [New Search]
